findmyKOL

Robert Fox, MD

Enriched profile

Staff Neurologist, Mellen Center for Multiple Sclerosis; Vice-Chair for Research, Neurological Institute, Cleveland Clinic · Cleveland Clinic

ORCIDNPI
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyNeurologyFocusMultiple Sclerosis
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1985–2025

Robert Fox is Staff Neurologist, Mellen Center for Multiple Sclerosis; Vice-Chair for Research, Neurological Institute, Cleveland Clinic at Cleveland Clinic. OpenAlex indexes 503 publications with 23,306 citations (h-index 66); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Robert Fox, MD, is Staff Neurologist, Mellen Center for Multiple Sclerosis at Cleveland Clinic, Neurological Institute / Mellen Center for Multiple Sclerosis, Cleveland, OH. The public record shows 503 publications with 23,306 citations (h-index 66), centered on Multiple Sclerosis. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 24 companies, 11 NIH-funded awards (1985–2025).

  • Most recent indexed publication: 2026 · Drugs
  • Top research focus: Multiple Sclerosis
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 24 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Sclerosis6 trials

Research focus

OpenAlex concept fingerprint
Multiple Sclerosis

Drugs & molecules

across trials, industry payments and publications
Tecfiderageneric · Dimethyl fumarateClinical trialsIndustry payments1Publications2Briumvigeneric · UblituximabClinical trialsIndustry payments13PublicationsOcrevusgeneric · OcrelizumabClinical trialsIndustry payments6Publications

Works with

trial sponsors and companies reporting payments
Genzyme CorporationClinical trialsIndustry payments19E.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments16Tg Therapeutics, Inc.Clinical trialsIndustry payments15

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
503publications

Distinct works indexed by OpenAlex, matched via ORCID; 56 in PubMed.

23,306citations

Total citations across indexed works.

66h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
24companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
11NIH grants · 1985–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

24 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    86.5%
    Sphingosine 1-phosphate Receptor Modulator38.5%
    Fingolimod51%Zeposia49%
    Part D<11 patients
    Other immunostimulants19.8%
    Glatopa100%
    Part D<11 patients
  • Musculoskeletal

    13.5%
    gamma-Aminobutyric Acid-ergic Agonist13.5%
    Baclofen100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

11 NIH research awards on record, funded 19852025 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/robert-fox-md-cbb32998

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Other

    consultqd.clevelandclinic.org/dr-robert-fox-receives-innovation-award-for-advances-in-progressive-multiple-sclerosis-video

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultqd.clevelandclinic.org
  • Spotify

    my.clevelandclinic.org/podcasts/neuro-pathways/progressive-multiple-sclerosis-contemporary-concepts-and-new-therapies

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org
  • Spotify

    open.spotify.com/show/7khhe0AXiM7tHefG7Gzilx

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • Guest

    Cleveland Clinic "Neuro Pathways" podcast: "Emerging Therapeutic Options in Progressive Multiple Sclerosis"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultqd.clevelandclinic.org
  • Guest

    Cleveland Clinic "Neuro Pathways" podcast: "Progressive Multiple Sclerosis: Contemporary Concepts & New Therapies"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →my.clevelandclinic.org
  • Guest

    RealTalk MS podcast Episode 355: "The NARCOMS Patient Registry with Dr. Robert Fox"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.